P09960 (LKHA4_HUMAN) Homo sapiens (Human)

Leukotriene A-4 hydrolase UniProtKBInterProSTRINGInteractive Modelling

611 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 3 identical sequences: Homo sapiens: A0A140VK27; Pan troglodytes: H2Q6N3, A0A6D2XEN6

Available Structures

76 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form II)
5ni4
homo-3-mer3-610
3×ZN; 7×IMD; 3×DJ3;
Assess
[E296Q]LTA4H in complex with RSR substrate
3b7s
monomer2-611
1×ZN; 1×YB; 1×ACY; 1×GOL;
Assess
Crystal structure of leukotriene a4 hydrolase in complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-a…
3cho
monomer2-611
1×ZN; 1×YB; 1×ACT; 1×4BG;
Assess
Complex of human leukotriene A4 hydrolase with a hydroxamic acid inhibitor
2vj8
monomer2-611
1×ZN; 3×YB; 1×IMD; 1×ACT; 1×HA2;
Assess
Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040
3b7r
monomer2-611
1×ZN; 1×YB; 1×IMD; 1×BIR;
Assess
Leukotriene A4 hydrolase complexed with inhibitor RB3041
2r59
monomer2-611
1×ZN; 1×YB; 1×PH0; 1×ACY;
Assess
Leukotriene A4 Hydrolase Complexed with KELatorphan
3b7u
monomer2-611
1×ZN; 3×YB; 1×IMD; 1×KEL; 1×ACY;
Assess
STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN.
1hs6
monomer2-611
1×ZN; 3×YB; 1×ACT; 1×BES; 1×IMD;
Assess
STRUCTURE OF [E271Q]LEUKOTRIENE A4 HYDROLASE
1h19
monomer2-611
1×ZN; 1×YB; 1×ACY; 1×IMD;
Assess
Crystal structure of leukotriene A4 hydrolase in complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-b…
3chr
monomer2-611
1×ZN; 1×YB; 1×4BS; 1×IMD;
Assess
STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT
1gw6
monomer2-611
1×BES; 1×ACT; 1×IMD; 1×YB; 1×ZN;
Assess
STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE
1sqm
monomer2-611
1×ZN; 1×YB; 1×IMD; 1×ACY;
Assess
[E296Q]LTA4H in complex with Arg-Ala-Arg substrate
3b7t
monomer2-611
1×ZN; 2×YB; 1×IMD;
Assess
Crystal structure of leukotriene A4 hydrolase in complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-…
3chs
monomer2-611
1×ZN; 3×YB; 1×IMD; 1×4BU;
Assess
Crystal structure of human LTA4H mutant D375N in open conformation (crystal form II)
5nid
monomer2-610
1×ZN;
Assess
Crystal structure of human LTA4H mutant D375N in open conformation (crystal form I)
5nia
monomer2-610
1×ZN;
Assess
Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A
3u9w
monomer4-611
1×ZN; 8×YB; 2×CL; 3×IMD; 1×GOL; 1×28P; 1×ACT;
Assess
Crystal structure of human LTA4H mutant D375N in complex with LTA4
5ni6
monomer4-611
1×ZN; 2×YB; 2×ACY; 1×DJ3;
Assess
Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue and 4-(4-benzylphenyl)thiazol-2…
4mkt
monomer4-611
1×ZN; 1×28T; 1×1V6; 2×YB; 2×ACY;
Assess
Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue
4ms6
monomer4-611
1×ZN; 1×28T; 5×YB; 2×ACY;
Assess
Structure of human Leukotriene A4 hydrolase in complex with inhibitor dimethyl(2- (4-phenoxyphenoxy…
5aen
monomer4-611
1×DP8; 1×ZN; 4×YB; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with 1-[2-(1H-indol-5-yloxy)ethyl]piperidine-4-carboxylic acid
3fuk
monomer4-611
1×ZN; 1×YB; 1×58Z; 1×ACT; 2×IMD;
Assess
LTA4 hydrolase in complex with Compound11
6enc
monomer4-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGW;
Assess
Crystal structure of leukotriene a4 hydrolase in complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethox…
3chp
monomer4-611
1×ZN; 1×YB; 1×ACT; 1×IMD; 1×4BO;
Assess
Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity
7llq
monomer4-611
1×ZN; 1×N0Y; 1×28T;
Assess
Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity
7kze
monomer4-611
1×ZN; 1×N0Y;
Assess
Leukotriene A4 hydrolase in complex with 4-(4-benzylphenyl)-oxazol-2-amine
8ava
monomer5-611
1×ZN; 4×YB; 4×ACT; 2×IMD; 1×OVO; 2×GOL;
Assess
Leukotriene A4 hydrolase in complex with 4-(4-Benzylphenyl)-selenazol-2-amine
8awh
monomer5-611
1×ZN; 3×YB; 4×ACT; 2×IMD; 1×OD6; 2×GOL;
Assess
Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form I)
5ni2
monomer4-610
1×ZN; 2×YB; 1×DJ3;
Assess
LTA4 hydrolase in complex with compound 6(R)
8qq4
monomer5-611
1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WEE;
Assess
Human Leukotriene A4 Hydrolase complexed with ligand 4-(4-benzylphenyl)thiazol-2-amine
4l2l
monomer5-611
1×ZN; 1×1V6; 4×YB; 3×ACT;
Assess
Structure of Human Leukotriene A4 Hydrolase in complex with inhibitor H1
4r7l
monomer4-610
1×ZN; 1×YB; 3×GOL; 2×ACT; 1×IMD; 1×SHH;
Assess
Leukotriene A4 Hydrolase complexed with inhibitor 1-[2-(4-benzylphenoxy)ethyl]pyrrolidine.
3fh8
monomer5-611
1×ZN; 3×YB; 1×ACT; 1×IMD; 1×27P;
Assess
Leukotriene A4 hydrolase in complex with fragment N-(pyridin-3-ylmethyl)aniline
3ftv
monomer5-611
1×ZN; 2×YB; 1×11X; 1×IMD;
Assess
LTA4 hydrolase in complex with fragment2
7av1
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZK;
Assess
Leukotriene A4 hydrolase in complex with fragment 4-(4-fluorobenzoyl)pyridine
3fu0
monomer5-611
1×ZN; 2×YB; 1×22F; 1×ACT; 1×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment 5-hydroxyindole and bestatin
3fuh
monomer5-611
1×ZN; 3×YB; 1×5H1; 1×BES; 1×IMD;
Assess
LTA4 hydrolase (E297Q) mutant in complex with Pro-Gly-Pro peptide
6enb
monomer5-611
1×ZN; 1×ACT; 2×YB; 1×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragments N-(pyridin-3-ylmethyl)aniline and acetate
3ftw
monomer5-611
1×ZN; 1×YB; 1×11X; 2×ACT; 2×IMD;
Assess
LTA4 hydrolase in complex with CTX-4430
8rx3
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3T;
Assess
LTA4 hydrolase in complex with compound2
8rx7
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3S;
Assess
LTA4 hydrolase in complex with compound R(13)
7av0
monomer5-611
1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZB;
Assess
LTA4 hydrolase in complex with compound LYS006
7auz
monomer5-611
1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZE;
Assess
Crystal Structure Analysis of the Human Leukotriene A4 Hydrolase
4rvb
monomer5-611
1×YB; 1×ZN; 2×ACT; 3×IMD; 2×GOL; 2×ACY;
Assess
Crystal structures of the Human leukotriene A4 Hydrolase complex with a potential inhibitor H7
4rsy
monomer5-611
1×B3N; 1×ZN; 1×YB; 1×ACY; 1×IMD;
Assess
LTA4 hydrolase in complex with fragment1
7av2
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZN;
Assess
Leukotriene A4 hydrolase in complex with dihydroresveratrol and bestatin
3ftx
monomer5-611
1×ZN; 3×YB; 1×RE2; 1×BES; 1×ACT; 1×IMD;
Assess
LTA4 hydrolase in complex with compound 6(S)
8qpn
monomer5-611
1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WSL;
Assess
Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril
4dpr
monomer5-611
1×ZN; 1×X8Z; 5×YB; 1×ACY; 2×GOL;
Assess
Structure of human Leukotriene A4 hydrolase in complex with inhibitor 4AZ
5bpp
monomer5-611
1×ZN; 3×YB; 1×ACT; 1×A4Z;
Assess
Apo structure of human Leukotriene A4 hydrolase
5fwq
monomer5-611
1×ACT; 1×ZN; 6×YB; 3×IMD;
Assess
Leukotriene A4 Hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}pyr…
3fh7
monomer5-611
1×ZN; 3×YB; 1×ACT; 1×IMD; 1×25P; 1×GOL;
Assess
Crystal structure of leukotriene a4 hydrolase in complex with N5-[4-(phenylmethoxy)phenyl]-L-glutam…
3chq
monomer4-610
1×ZN; 3×YB; 1×IMD; 1×4BQ;
Assess
Leukotriene A4 Hydrolase complexed with inhibitor N-[3-(4-benzylphenoxy)propyl]-N-methyl-beta-alani…
3fhe
monomer5-611
1×ZN; 3×YB; 1×ACT; 1×IMD; 1×28P;
Assess
LTA4 hydrolase in complex with Compound15
6end
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGK;
Assess
Leukotriene A4 hydrolase in complex with resveratrol
3fts
monomer5-611
1×ZN; 1×YB; 1×STL; 1×ACT; 1×IMD;
Assess
LTA4 hydrolase in complex with compound 2(S)
8qow
monomer5-611
1×ZN; 1×ACT; 2×YB; 2×IMD; 1×WID;
Assess
Leukotriene A4 hydrolase in complex with fragment 5-chloroindole and bestatin
3fue
monomer5-611
1×ZN; 3×YB; 1×11S; 1×BES; 1×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment 5-fluoroindole and bestatin
3fuf
monomer5-611
1×ZN; 3×YB; 1×14O; 1×BES; 1×IMD;
Assess
The effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activ…
6o5h
monomer5-611
1×LNJ; 1×ZN;
Assess
LTA4 hydrolase in complex with compound3
8rx9
monomer5-611
1×ZN; 1×ACT; 3×YB; 2×IMD; 1×A1H3U;
Assess
Leukotriene A4 hydrolase in complex with {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphe…
3fun
monomer5-610
1×ZN; 1×YB; 1×798; 1×ACT; 2×IMD;
Assess
Leukotriene A4 Hydrolase complexed with inhibitor (2R)-2-[(4-benzylphenoxy)methyl]pyrrolidine.
3fh5
monomer5-610
1×ZN; 2×YB; 1×ACT; 2×IMD; 1×24P; 1×GOL;
Assess
Leukotriene A4 hydrolase in complex with dihydroresveratrol
3ftu
monomer5-610
1×ZN; 1×YB; 1×RE2; 1×ACT; 1×IMD;
Assess
Leukotriene A4 hydrolase in complex with 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole
3fuj
monomer5-610
1×ZN; 1×YB; 1×00G; 1×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment 2-(pyridin-3-ylmethoxy)aniline
3ftz
monomer5-610
1×ZN; 1×YB; 1×848; 3×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment 4-(2-amino-1,3-thiazol-4-yl)phenol
3fu3
monomer5-610
1×ZN; 1×YB; 2×92G; 2×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment (4-thiophen-2-ylphenyl)methanamine
3fu6
monomer5-610
1×ZN; 1×YB; 1×80G; 2×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with fragment 3-(benzyloxy)pyridin-2-amine
3fty
monomer5-610
1×ZN; 1×YB; 1×3IP; 3×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with N-methyl-1-(2-thiophen-2-ylphenyl)methanamine
3fud
monomer5-610
1×ZN; 1×YB; 1×692; 1×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline
3fui
monomer6-611
3×YB; 1×ZN; 1×812; 1×IMD;
Assess
Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine
3fu5
monomer5-610
1×ZN; 1×YB; 1×492; 1×ACT; 2×IMD;
Assess
Crystal structure of LTA4H bound to a selective inhibitor against LTB4 generation
5n3w
monomer5-610
1×ZN; 1×YB; 1×IMD; 1×8KW; 1×ACT;
Assess
Crystal structure of human LTA4H mutant R563A in open conformation
5nie
monomer5-610
1×ZN;
Assess
Leukotriene A4 hydrolase in complex with (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol
3fum
monomer6-610
1×ZN; 1×YB; 1×80A; 1×ACT; 2×IMD;
Assess
Leukotriene A4 hydrolase in complex with pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone
3ful
monomer6-610
1×ZN; 1×YB; 1×52D; 2×IMD;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3cho.1.Amonomer0.912-611
1×ZN; 1×4BG;100.00
Assess

3 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24rvb.1.Amonomer0.925-519
1×ZN; 2×IMD;98.65
Assess
Isoform 33cho.1.Amonomer0.9130-495
1×ZN; 1×4BG;98.50
Assess
Isoform 43b7r.1.Amonomer0.9227-587
1×ZN; 1×IMD; 1×BIR;99.47
Assess